Becky Raby, MD
Allergy & Immunology · Huntsville, ALNPI 1295712933
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 36.0% of the total. That places this record below the midpoint for allergy & immunology clinicians in AL, where the typical reported total is $8,006.
Across 117 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$803
- Takeda Pharmaceuticals U.S.A., Inc.$440
- CSL Behring$431
- Sanofi$122
- Novartis$122
- Genentech USA, Inc.$70
- plus $244 from 10 others
What the payments were for
- Food & beverage$2,233100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 38 | $803 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $440 |
| CSL Behring | 20 | $431 |
| Sanofi | 7 | $122 |
| Novartis | 7 | $122 |
| Genentech USA, Inc. | 5 | $70 |
| UCB, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 2 | $32 |
| GSK | 2 | $31 |
| Optinose US, Inc. | 2 | $27 |
| Grifols USA, LLC | 1 | $20 |
| Amgen | 1 | $14 |
| Almirall LLC | 1 | $13 |
| Dermira, Inc. | 1 | $12 |
| Kaleo, Inc. | 1 | $11 |
How this compares
$2,233 in reported general payments places this provider in the 25th percentile of 30 allergy & immunology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 34 | $153,094 |
| XolairOmalizumab | 29 | $79,667 |
| Epinephrine | 15 | $4,720 |
| Ipratropium Bromide | 28 | $2,122 |
| Azelastine Hcl | 17 | $590 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $499 |
| Fluticasone Propionate | 12 | $457 |
| Famotidine | 19 | $363 |
| Montelukast Sodium | 20 | $135 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Huntsville
- Heather JamesHuntsville$3K
- Kaleswara Rao AllamneniHuntsville$115
- Mary RaileyHuntsville$22
- John AndersonHomewood$789K
- Joseph ForesterCullman$719K
- William DavidsonDaphne$98K
- Thomas ScottBessemer$61K
- Thomas AtkinsonBirmingham$53K
- Njeri MainaBirmingham$44K
- Michael PolcariBirmingham$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.